Background Leading News Today : Breaking News, Live Updates & Top Stories | Vimarsana

To embed, copy and paste the code into your website or blog: On November 30, 2020, the U.S. Department of Health and Human Services (“HHS”) Office of Inspector General (“OIG”) published a final rule (“Final Rule”) that removes safe harbor protection under the discount safe harbor to the federal Anti-Kickback Statute (“AKS”) for certain pharmaceutical rebates and creates two new safe harbors governing certain pharmaceutical manufacturer price reductions at the point of sale (“POS”) and certain pharmacy benefit manager (“PBM”) service fees.[1] While the new safe harbors become effective January 29, 2021, the removal of the discount safe harbor has a delayed effective date of January 1, 2022.[2] The Final Rule, if fully implemented, will have a significant impact on drug supply chain stakeholders operating under Medicare Part D, including health plans, PBMs, pharmaceutical manufacturers, drug wholesalers, and pharmacies.

United statesXavier becerraDepartment of justiceCenters for medicare medicaid servicesService feesWakely consulting groupCare management associationUs department of healthHuman servicesOffice of inspectorOffice of the actuaryBiden administrationMilliman incEpstein beckerInspector generalAnti kickback statute